PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Docetaxel
Presentation Product Chemical substance Chapter Items dispensed
Docetaxel 140mg/7ml solution for infusion vials
0801050D0AAAHAH
Docetaxel Docetaxel Malignant Disease and Immunosuppression No data available
Docetaxel 160mg/16ml solution for infusion vials
0801050D0AAAGAG
Docetaxel Docetaxel Malignant Disease and Immunosuppression No data available
Docetaxel 160mg/8ml solution for infusion vials
0801050D0AAAIAI
Docetaxel Docetaxel Malignant Disease and Immunosuppression No data available
Docetaxel 20mg/0.5ml solution for infusion vials and diluent
0801050D0AAAAAA
Docetaxel Docetaxel Malignant Disease and Immunosuppression No data available
Docetaxel 20mg/0.72ml inf vials and diluent
0801050D0AAALAL
Docetaxel Docetaxel Malignant Disease and Immunosuppression No data available
Docetaxel 20mg/1ml solution for infusion vials
0801050D0AAACAC
Docetaxel Docetaxel Malignant Disease and Immunosuppression No data available
Docetaxel 20mg/2ml solution for infusion vials
0801050D0AAAEAE
Docetaxel Docetaxel Malignant Disease and Immunosuppression No data available
Docetaxel 80mg/2.88ml inf vials and diluent
0801050D0AAAMAM
Docetaxel Docetaxel Malignant Disease and Immunosuppression No data available
Docetaxel 80mg/2ml solution for infusion vials and diluent
0801050D0AAABAB
Docetaxel Docetaxel Malignant Disease and Immunosuppression No data available
Docetaxel 80mg/4ml solution for infusion vials
0801050D0AAADAD
Docetaxel Docetaxel Malignant Disease and Immunosuppression No data available
Docetaxel 80mg/8ml solution for infusion vials
0801050D0AAAFAF
Docetaxel Docetaxel Malignant Disease and Immunosuppression No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.